|
1
|
Zhang L, Zhou X, Yao X, Wu Y and Zhang Q:
Oral tongue cancer patients show a better overall survival than
base of tongue cancer patients. J Cancer Res Clin Oncol.
138:341–346. 2012. View Article : Google Scholar
|
|
2
|
Arosarena OA, Madsen M and Haug R: Special
considerations with floor of mouth and tongue cancer. Oral
Maxillofac Surg Clin North Am. 18:521–531. 2006. View Article : Google Scholar
|
|
3
|
Beenken SW and Urist MM: Head and Neck
Tumors. Current surgical diagnosis and treatment. Way LW and
Doherty GM: Lange Medical Books/McGraw-Hill; New York: pp. 282–297.
2003
|
|
4
|
World Health Organisation: World Cancer
Report. 2008
|
|
5
|
National Cancer Research Institute:
Surveillance, Epidemiology, and End Results (SEER) program.
2004
|
|
6
|
Andreadis C, Vahtsevanos K, Sidiras T,
Thomaidis I, Antoniadis K and Mouratidou D: 5-Fluorouracil and
cisplatin in the treatment of advanced oral cancer. Oral Oncol.
39:380–385. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Galluzzi L, Senovilla L, Vitale I, et al:
Molecular mechanisms of cisplatin resistance. Oncogene.
31:1869–1883. 2012. View Article : Google Scholar
|
|
8
|
Zhang N, Yin Y, Xu SJ and Chen WS:
5-Fluorouracil: Mechanisms of resistance and reversal strategies.
Molecules. 13:1551–1569. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nathwani SM, Butler S, Fayne D, et al:
Novel micro-tubule-targeting agents, pyrrolo-1,5-benzoxazepines,
induce apoptosis in multi-drug-resistant cancer cells. Cancer
Chemother Pharmacol. 66:585–596. 2010. View Article : Google Scholar
|
|
10
|
McElligott AM, Maginn EN, Greene LM, et
al: The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15
induces apoptosis in poor prognostic subgroups of chronic
lymphocytic leukemia. Cancer Res. 69:8366–8375. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bright SA, McElligott AM, O'Connell JW, et
al: Novel pyrrolo-1,5-benzoxazepine compounds display significant
activity against resistant chronic myeloid leukaemia cells in
vitro, in ex vivo patient samples and in vivo. Br J Cancer.
102:1474–1482. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maginn EN, Browne PV, Hayden P, et al:
PBOX-15, a novel microtubule targeting agent, induces apoptosis,
upregulates death receptors, and potentiates TRAIL-mediated
apoptosis in multiple myeloma cells. Br J Cancer. 104:281–289.
2011. View Article : Google Scholar :
|
|
13
|
Li YM and Broome JD: Arsenic targets
tubulins to induce apoptosis in myeloid leukemia cells. Cancer Res.
59:776–780. 1999.PubMed/NCBI
|
|
14
|
Woods CM, Zhu J, McQueney PA, Bollag D and
Lazarides E: Taxol-induced mitotic block triggers rapid onset of a
p53-independent apoptotic pathway. Mol Med. 1:506–526.
1995.PubMed/NCBI
|
|
15
|
Mulligan JM, Greene LM, Cloonan S, et al:
Identification of tubulin as the molecular target of
proapoptoticpyrrolo-1,5-ben-zoxazepines. Mol Pharmacol. 70:60–70.
2006.PubMed/NCBI
|
|
16
|
Greene LM, Fleeton M, Mulligan J, et al:
The pyrrolo-1,5-ben-zoxazepine, PBOX-6, inhibits the growth of
breast cancer cells in vitro independent of estrogen receptor
status and inhibits breast tumour growth in vivo. Oncol Rep.
14:1357–1363. 2005.PubMed/NCBI
|
|
17
|
Nathwani SM, Cloonan SM, Stronach M, et
al: Novel micro-tubule-targeting agents,
pyrrolo-1,5-benzoxazepines, induce cell cycle arrest and apoptosis
in prostate cancer cells. Oncol Rep. 24:1499–1507. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mc Gee MM, Campiani G, Ramunno A, et al:
Activation of the c-Jun N-terminal kinase (JNK) signaling pathway
is essential during PBOX-6-induced apoptosis in chronic myelogenous
leukemia (CML) cells. J Biol Chem. 277:18383–18389. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kaneda Y, Shimamoto H, Matsumura K, et al:
Role of caspase 8 as a determinant in chemosensitivity of
p53-mutated head and neck squamous cell carcinoma cell lines. J Med
Dent Sci. 53:57–66. 2006.PubMed/NCBI
|
|
20
|
Bunz F, Hwang PM, Torrance C, et al:
Disruption of p53 in human cancer cells alters the responses to
therapeutic agents. J Clin Invest. 104:263–269. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jackson JG, Pant V, Li Q, Chang LL,
Quintas-Cardama A, Garza D, Tavana O, Yang P, Manshouri T, Li Y,
El-Naggar AK and Lozano G: p53-mediated senescence impairs the
apoptotic response to chemotherapy and clinical outcome in breast
cancer. Cancer Cell. 21:793–806. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Verma NK, Dempsey E, Conroy J, et al: A
new micro-tubule-targeting compound PBOX-15 inhibits T-cell
migration via post-translational modifications of tubulin. J Mol
Med. 86:457–469. 2008. View Article : Google Scholar
|
|
23
|
Rudner AD and Murray AW: The spindle
assembly checkpoint. Curr Opin Cell Biol. 8:773–780. 1996.
View Article : Google Scholar : PubMed/NCBI
|
